Charles Percy

Consultant Haematologist
University Hospitals Birmingham NHS Foundation Trust

Presentation(s):

• PB0297 - The use of Obinutuzumab and Ofatumumab in the treatment of immune Thrombotic Thrombocytopenic Purpura

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 30.1 - Emicizumab prophylaxis in people with severe haemophilia A without inhibitors: outcomes from the UK Haemophilia Centre Doctors' Organisation

  Monday, July 11, 2022
  10:45 AM – 11:00 AM